Telomir Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-13.07	-0.85	-0.14
Other Operating Activities	9.21	0.39	0.02
Operating Cash Flow	-3.86	-0.47	-0.12
Share Issuance / Repurchase	1	0.06	0
Debt Issued / Paid	3.12	0.46	0.12
Other Financing Activities	-0.26	-0.05	-
Financing Cash Flow	3.86	0.47	0.12
Net Cash Flow	-0	0	0
Free Cash Flow	-3.86	-0.47	-0.12
Free Cash Flow Per Share	-0.14	-0.02	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).